KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Restructuring Costs (2016 - 2020)

Zimmer Biomet Holdings has reported Restructuring Costs over the past 6 years, most recently at $8.1 million for Q4 2020.

  • Quarterly results put Restructuring Costs at $8.1 million for Q4 2020, up 118.92% from a year ago — trailing twelve months through Dec 2020 was $23.8 million (up 95.08% YoY), and the annual figure for FY2020 was $23.8 million, up 95.08%.
  • Restructuring Costs for Q4 2020 was $8.1 million at Zimmer Biomet Holdings, down from $9.1 million in the prior quarter.
  • Over the last five years, Restructuring Costs for ZBH hit a ceiling of $191.4 million in Q4 2016 and a floor of -$14.4 million in Q4 2018.
  • Median Restructuring Costs over the past 5 years was $27.2 million (2017), compared with a mean of $44.1 million.
  • Biggest five-year swings in Restructuring Costs: crashed 120.6% in 2018 and later surged 450.0% in 2020.
  • Zimmer Biomet Holdings' Restructuring Costs stood at $191.4 million in 2016, then tumbled by 63.48% to $69.9 million in 2017, then crashed by 120.6% to -$14.4 million in 2018, then skyrocketed by 125.69% to $3.7 million in 2019, then surged by 118.92% to $8.1 million in 2020.
  • The last three reported values for Restructuring Costs were $8.1 million (Q4 2020), $9.1 million (Q3 2020), and $2.2 million (Q2 2020) per Business Quant data.